Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Amping up With PemJAK [Phase 2]
A Phase 2 clinical trial of PemJAK for multiple lymphoma subtypes is currently recruiting, including non-Hodgkin lymphoma and Hodgkin lympho…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma [Phase 1]
A Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes for Epstein-Barr virus–associated lymphomas, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma [Phase 3]
This clinical trial update describes an ongoing Phase 3 study evaluating PET-guided dose reduction for involved-site radiotherapy in early-s…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy [Phase 2]
This clinical trial update describes a Phase 2 study evaluating frontline tislelizumab in patients with de novo Hodgkin lymphoma who are uns…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Genetic Markers of Susceptibility to Chemotherapy-induced Ovarian Damage in Cancer Patients Undergoing Ovarian Biopsy for Cryopreservation.
This clinical trial investigates genetic markers that predict susceptibility to chemotherapy-induced ovarian damage in cancer patients under…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
This ClinicalTrials.gov entry describes a recruiting USC-led study evaluating social health, activity behaviors, and quality of life among y…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Mozobil for Autologous Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial update for Mozobil (plerixafor) in autologous hematopoietic stem cell transplantation, enrolling patients with multip…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Nivo40-AVD for Advanced Classic Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating nivolumab plus AVD (Nivo40-AVD) in adults with advanced classic Hodgkin lymphoma; currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma [Phase 2]
A Phase 2 trial evaluating the combination of nivolumab and axatilimab in relapsed or refractory classical Hodgkin lymphoma, currently recru…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Personalized NK Cell Therapy in CBT [Phase 2]
A Phase 2 trial from MD Anderson is evaluating personalized NK cell therapy across several hematologic cancers. The study is currently recru…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Auto Stem Cell Transplant for Lymphoma Patients [Phase 2]
This Phase 2 clinical trial registry entry describes autologous stem cell transplantation as a treatment approach for non-Hodgkin lymphoma a…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta) [Phase 1]
Phase 1 trial evaluating autologous/allogeneic TGF-beta-resistant LMP-specific cytotoxic T lymphocytes for lymphoma; the study is active but…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Two Step Haplo With Radiation Conditioning [Phase 2]
Phase 2 clinical trial update describing two-step haploidentical transplantation with radiation conditioning for hematologic diseases, curre…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ATLCAR.CD30.CCR4 for CD30+ Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study of the monoclonal antibody IMT-009 in various advanced solid tumors and lymphomas, with t…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors [Phase 1]
Phase 1 pediatric trial evaluating alpha/beta CD19+ depleted haploidentical transplantation in combination with Zoledronic acid (Zometa) for…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
Expanded Access program for AVM0703 is available to eligible patients with several solid tumor and blood cancer indications, including gliob…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating the combination of nivolumab and lenalidomide in relapsed or refractory lymphomas (non-Hodgkin an…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies [EARLY_Phase 1]
An early-phase trial evaluating Darzalex Faspro (daratumumab and hyaluronidase-fihj) given before desensitization and allogeneic stem cell t…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Integrated Actionable Aging Assessment for Cancer Patients Pilot [NA]
This entry summarizes a pilot trial from University of Colorado, Denver to develop an integrated aging assessment for cancer patients; the s…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation [NA]
This document provides an update on a clinical trial evaluating cardiac screening in survivors of Hodgkin lymphoma treated with mediastinal …
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
A clinical trial assessing Adcetris (brentuximab vedotin) in adults with Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma. [Phase 1]
A Phase 1 clinical trial led by Murdoch Children's Research Institute is investigating changes in metabolism phenotype in paediatric, adoles…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. [NA]
This clinical trial update describes a post-treatment program to identify and manage complications related to oncology or hematology treatme…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
A completed Stanford-led clinical trial evaluating wearable sensors and molecular omics approaches to detect and mitigate adverse events dur…